Mark Schrader

6.3k citations

136 papers · 4.1k indexed · h-index 33

Cancer Research top 2%
Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research 33
- Prostate Cancer Diagnosis and Treatment 22
- Renal cell carcinoma treatment 15
Sensory Systems top 2%
Urology top 2%
- Urological Disorders and Treatments 13
Reproductive Medicine top 2%
- Sperm and Testicular Function 13
Surgery
- Bladder and Urothelial Cancer Treatments 27
- Testicular diseases and treatments 21
Molecular Biology
- Epigenetics and DNA Methylation 15

Co-authors: Kurt Miller Hans Krause Markus Müller Andres Jan Schrader Steffen Weikert Frank Christoph Michael Lein Florian Jentzmik
Cited by: Cancer Research Pulmonary and Respiratory Medicine Sensory Systems
Journals: World Journal of Urology (9 papers)The Journal of Urology (8 papers)International Journal of Cancer (6 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Mark Schrader

132 papers receiving 4.0k citations

Peers

Countries citing papers authored by Mark Schrader

Since Specialization

Citations

This map shows the geographic impact of Mark Schrader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Schrader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Schrader more than expected).

Fields of papers citing papers by Mark Schrader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Schrader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Schrader. The network helps show where Mark Schrader may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Schrader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Schrader Line = papers co-authored together Mark Schrader links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Individual and dyadic planning predicting pelvic floor exercise among prostate cancer survivors. Rehabilitation Psychology ·Jan Keller,Silke Burkert,Amelie U. Wiedemann,Aleksandra Łuszczyńska,Mark Schrader,Nina Knoll	2015	10
2	Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma BMC Cancer ·Frederik C. Roos,Sandra Steffens,Kerstin Junker,Martin Janssen,Frank Becker,Gerd Wegener,Walburgis Brenner,Julie Steinestel,Thomas Schnoeller,Mark Schrader,Rainer Hofmann,Joachim W. Thüroff,Markus A. Kuczyk,Heiko Wunderlich,Stefan Siemer,Arndt Hartmann,Michael Stöckle,Andres Jan Schrader,(unknown)	2014	26
3	Comparison of surgical technique (Open vs. Laparoscopic) on pathological and long term functional outcomes following radical prostatectomy BMC Urology ·Ahmed Magheli,Jonas Busch,Dody H. Sasmita,Mark Schrader,Serdar Değer,Kurt Miller,Michael Lein	2014	18
4	Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARΔLBD-Signalling in Human Prostate Cancer Cells PLoS ONE ·E.M. van Dam-Havelková,Manuel Luedeke,資源エネルギ-庁省エネルギ-・石油代替エネルギ-対策課,Friedemann Zengerling,Li Tian,Felicitas Genze,Mark Schrader,Andres Jan Schrader,Marcus V. Cronauer	2014	23
5	Prostate cancer patients gradually advance goals for rehabilitation after radical prostatectomy: Applying a lines-of-defense model to rehabilitation. Psychology and Aging ·Nina Knoll,Amelie U. Wiedemann,Martin Schultze,Mark Schrader,Jutta Heckhausen	2014	12
6	The Fuhrman grading system has no prognostic value in patients with nonsarcomatoid chromophobe renal cell carcinoma Human Pathology ·Sandra Steffens,Martin Janssen,Frederik C. Roos,Frank Becker,Julie Steinestel,Mahmoud Abbas,Konrad Steinestel,Gerd Wegener,Stefan Siemer,Joachim W. Thüroff,Rainer Hofmann,Michael Stöckle,Mark Schrader,Arndt Hartmann,Andrea Hasenfus,Markus A. Kuczyk,Kerstin Junker,Andres Jan Schrader	2014	11
7	Interdisciplinary decision making in prostate cancer therapy – 5-years’ time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin BMC Medical Informatics and Decision Making ·D. Baumunk,Jana-Lea Davidson,Rio Tanabashi,Hui Xue,Carsten Kempkensteffen,Ursula Steiner,Steffen Weikert,Matti Supponen,Mark Schrader,Stefan Höcht,Thomas Wiegel,Kurt Miller,Martin Schostak	2013	7
8	Overexpression of p16INK4a in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection PLoS ONE ·Julie Steinestel,Marcus V. Cronauer,Johannes Müller,Zukhaira Hayati,Doan Thi Hong Viet,Annette Arndt,K. Kraft,Mark Schrader,Andres Jan Schrader,Konrad Steinestel	2013	35
9	Prostate Cancer Risk Is not Altered by TP53AIP1 Germline Mutations in a German Case-Control Series PLoS ONE ·Manuel Luedeke,Annelies Signer,Mario Van Strahlen Pérez,Natalia Bogdanova,Antje E. Rinckleb,Mark Schrader,Walther Vogel,Josef Hoegel,Andreas Meyer,Thilo Dörk,Christiane Maier	2012	6
10	JS-K, a glutathione/glutathione S-transferase-activated nitric oxide releasing prodrug inhibits androgen receptor and WNT-signaling in prostate cancer cells BMC Cancer ·François Ronde-Oustau,Klaus‐Dieter Spindler,Andres Jan Schrader,E Martins,E.M. van Dam-Havelková,Mark Schrader,Marcus V. Cronauer	2012	41
11	The ileal neobladder in female patients with bladder cancer: long-term clinical, functional, and oncological outcome World Journal of Urology ·Florian Jentzmik,Andres Jan Schrader,R. de Petriconi,Schmauss,Johannes Mueller,Boudewijn Servaes Jan Visschers,Alexander Eickhoff,Mark Schrader	2012	35
12	The German S3 Guideline Prostate Cancer Strahlentherapie und Onkologie ·Frederik Wenz,Thomas J. Martin,Dirk Böhmer,田代伸一,Felix Sedlmayer,Manfred P. Wirth,Kurt Miller,Axel Heidenreich,Mark Schrader,W. Hinkelbein,Thomas Wiegel	2010	16
13	Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours European Urology ·Florian Jentzmik,Carsten Stephan,Kurt Miller,Mark Schrader,Andreas Erbersdobler,Glen Kristiansen,Michael Lein,Klaus Jung	2010	192
14	Transient receptor potential canonical type 3 channels and blood pressure in humans Journal of Hypertension ·Florian Thilo,D. Baumunk,Hans Krause,Mark Schrader,Kurt Miller,Christoph Loddenkemper,Andreas Zakrzewicz,Katharina Krueger,Walter Zidek,Martin Tepel	2009	20
15	The equilibrium of XIAP and Smac/DIABLO expression is gradually deranged during the development and progression of testicular germ cell tumours International Journal of Andrology ·Carsten Kempkensteffen,Djenaro Barchelot Plata,JOANNA KWAŚNIEWSKA,Steffen Weikert,Stefan Hinz,Frank Christoph,Hans Krause,Martin Schostak,Kurt Miller,Mark Schrader	2007	20
16	Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors Journal of Cancer Research and Clinical Oncology ·Carsten Kempkensteffen,Frank Christoph,Steffen Weikert,Hans Krause,Jens Köllermann,Martin Schostak,Kurt Miller,Mark Schrader	2006	15
17	Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance International Journal of Cancer ·Carsten Kempkensteffen,Stefan Hinz,Frank Christoph,Jens Köllermann,Hans Krause,Mark Schrader,Martin Schostak,Kurt Miller,Steffen Weikert	2006	27
18	Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer International Journal of Cancer ·Steffen Weikert,Hans Krause,Ingmar Wolff,Frank Christoph,Mark Schrader,Thomas Emrich,Kurt Miller,Markus Müller	2005	30
19	Quantification of cyclin A1 and glyceraldehyde‐3‐phosphate dehydrogenase expression in testicular biopsies of infertile patients by fluorescence real‐time RT‐PCR International Journal of Andrology ·Mark Schrader,Stuart E. Ravnik,Carsten Müller‐Tidow,Markus Müller,Bernd F. Straub,T Johnny,Hubert Serve,Kurt Miller	2002	4
20	The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase BMC Cancer ·Mark Schrader,Angelika M. Burger,Markus Müller,Hans Krause,Bernd F. Straub,Martin Schostak,Wolfgang Schulze,Heidrun Lauke,Kurt Miller	2002	13

About Mark Schrader

Mark Schrader is a scholar working on Urology, Reproductive Medicine, Pulmonary and Respiratory Medicine, Neuropsychology and Physiological Psychology and Surgery, having authored 136 papers that have together received 4.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (33 papers), Bladder and Urothelial Cancer Treatments (27 papers), Prostate Cancer Diagnosis and Treatment (22 papers), Testicular diseases and treatments (21 papers), Renal cell carcinoma treatment (15 papers), Epigenetics and DNA Methylation (15 papers), Urological Disorders and Treatments (13 papers) and Sperm and Testicular Function (13 papers). The work is most often cited by research in Cancer Research (760 citations), Pulmonary and Respiratory Medicine (1.4k citations), Sensory Systems (189 citations), Urology (219 citations) and Reproductive Medicine (281 citations). Mark Schrader has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Kurt Miller, Hans Krause, Markus Müller, Andres Jan Schrader, Steffen Weikert, Frank Christoph, Michael Lein, Florian Jentzmik, Klaus Jung and Martin Schostak. Their work appears in journals such as World Journal of Urology, The Journal of Urology, International Journal of Cancer, Cancer Letters and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact